We are live on
!
Find out more
BCM
Brown Capital Management Portfolio holdings
AUM
$500M
Turnover
25.4%
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
-22.5%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$8.31B
AUM Growth
-$2.7B
(-25%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
45%
Holding
128
New
4
Increased
49
Reduced
49
Closed
6
Avg Time Held
3.8
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
3.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Glaukos
GKOS
|
+$139M |
| 2 |
AYX
Alteryx Inc
AYX
|
+$109M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$50.4M |
| 4 |
Q2 Holdings
QTWO
|
+$48.3M |
| 5 |
ELLI
Ellie Mae Inc
ELLI
|
+$38.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$74.5M |
| 2 |
Paycom
PAYC
|
+$63.1M |
| 3 |
Ansys
ANSS
|
+$61.4M |
| 4 |
Bio-Techne
TECH
|
+$61.1M |
| 5 |
Balchem Corp
BCPC
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.07% |
| 2 | Healthcare | 34.36% |
| 3 | Industrials | 12.6% |
| 4 | Materials | 3.86% |
| 5 | Consumer Discretionary | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Paycom
PAYC
$10.8B
| $430M | 5.17% |
3,511,183
-492,614
| -12% | -$63.1M |
2016 Q4
8 quarters
|
|
2
Protolabs
PRLB
$2.13B
| $419M | 5.04% |
3,712,611
-3,772
| -0.1% | -$465K |
2014 Q2
18 quarters
|
|
|
3
Veeva Systems
VEEV
$48.1B
| $413M | 4.97% |
4,623,556
-815,216
| -15% | -$74.5M |
2015 Q2
14 quarters
|
|
|
ABMD
4
DELISTED
Abiomed Inc
ABMD
| $403M | 4.85% |
1,241,145
-22,066
| -2% | -$7.67M |
2016 Q1
11 quarters
|
|
5
Tyler Technologies
TYL
$14.3B
| $389M | 4.67% |
2,090,749
+29
| +0% | +$5.73K |
2013 Q2
22 quarters
|
|
6
Cognex
CGNX
$9.63B
| $380M | 4.57% |
9,824,183
+68,767
| +0.7% | +$2.98M |
2013 Q2
22 quarters
|
|
7
Neogen
NEOG
$2.65B
| $365M | 4.39% |
12,815,302
+89,308
| +0.7% | +$2.79M |
2013 Q2
22 quarters
|
|
8
Manhattan Associates
MANH
$12.8B
| $351M | 4.22% |
8,284,578
-275,883
| -3% | -$13.1M |
2013 Q2
22 quarters
|
|
|
9
Balchem Corp
BCPC
$5.43B
| $303M | 3.64% |
3,863,010
-457,082
| -11% | -$41.3M |
2013 Q2
22 quarters
|
|
10
Blackbaud
BLKB
$2.22B
| $288M | 3.46% |
4,573,463
+53,564
| +1% | +$3.86M |
2013 Q2
22 quarters
|
|
|
11
DELISTED
Ansys
ANSS
| $285M | 3.42% |
1,991,104
-395,022
| -17% | -$61.4M |
2013 Q2
22 quarters
|
|
|
ELLI
12
DELISTED
Ellie Mae Inc
ELLI
| $283M | 3.4% |
4,499,826
+541,588
| +14% | +$38.6M |
2015 Q1
15 quarters
|
|
|
MDSO
13
DELISTED
Medidata Solutions, Inc.
MDSO
| $277M | 3.33% |
4,102,664
-237,603
| -5% | -$16.8M |
2013 Q2
22 quarters
|
|
14
QuidelOrtho
QDEL
$951M
| $270M | 3.25% |
5,540,224
-11,175
| -0.2% | -$667K |
2013 Q2
22 quarters
|
|
|
CMD
15
DELISTED
Cantel Medical Corporation
CMD
| $268M | 3.23% |
3,600,471
+214,254
| +6% | +$17.7M |
2013 Q2
22 quarters
|
|
16
Inogen
INGN
$163M
| $265M | 3.19% |
2,136,245
-65,790
| -3% | -$10.8M |
2016 Q2
10 quarters
|
|
17
Guidewire Software
GWRE
$13.5B
| $264M | 3.17% |
3,286,845
-60,121
| -2% | -$5.24M |
2015 Q1
15 quarters
|
|
|
18
Bio-Techne
TECH
$11.4B
| $246M | 2.96% |
6,809,696
-1,462,736
| -18% | -$61.1M |
2013 Q2
22 quarters
|
|
|
VCRA
19
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $214M | 2.57% |
5,427,450
-109,754
| -2% | -$3.97M |
2013 Q2
22 quarters
|
|
20
Helios Technologies
HLIO
$2.25B
| $191M | 2.3% |
5,752,164
+5,100
| +0.1% | +$216K |
2013 Q2
22 quarters
|
|
21
DELISTED
PROS Holdings
PRO
| $175M | 2.11% |
5,580,504
+5,138
| +0.1% | +$163K |
2013 Q2
22 quarters
|
|
22
ACI Worldwide
ACIW
$5.16B
| $164M | 1.97% |
5,910,257
-1,225,719
| -17% | -$33.2M |
2013 Q2
22 quarters
|
|
23
Alarm.com
ALRM
$2.78B
| $144M | 1.73% |
2,778,858
+53,432
| +2% | +$2.58M |
2018 Q1
3 quarters
|
|
|
NXGN
24
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $143M | 1.72% |
9,413,589
-16,938
| -0.2% | -$291K |
2013 Q2
22 quarters
|
|
|
25
Q2 Holdings
QTWO
$3.71B
| $131M | 1.57% |
2,639,528
+947,109
| +56% | +$48.3M |
2018 Q3
1 quarter
|
|
Similar funds
HC
TLP
ISWM
PT
FGWP
PCA
FNBOMD
TPWM
Brown Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Brown Capital Management held 128 positions worth $8.31B, down 25% from $11B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Brown Capital Management's Q4 2018 filing shows 4 new, 49 increased, 49 reduced and 6 closed positions. Its largest new stake was Glaukos: 2,314,255 shares worth $130M. The largest sale was Veeva Systems, an estimated $74.5M.
By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 46% a quarter earlier, followed by Healthcare and Industrials.
- Brown Capital Management's largest Q4 2018 buy was Glaukos: 2,314,255 shares worth $130M.
- Brown Capital Management added most to Ironwood Pharmaceuticals in Q4 2018, an estimated $50.4M increase.
- Brown Capital Management's biggest Q4 2018 reduction was Veeva Systems, cutting an estimated $74.5M.
- Brown Capital Management fully exited Zoe's Kitchen, Inc. in Q4 2018, selling an estimated $41.1M.
- Brown Capital Management's ten largest holdings make up 45% of its $8.31B portfolio in Q4 2018.
- Brown Capital Management opened 4 new positions and closed 6 in Q4 2018.
- Brown Capital Management's portfolio value fell 25% quarter-over-quarter to $8.31B.
Based on Brown Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.